Table 2.
Susceptibility test results of all isolates
| Antibiotics (μg) | Escherichia coli | Klebsiella pneumoniae | Pseudomonas aeruginosa | Total | ||||
|---|---|---|---|---|---|---|---|---|
| S n (%) |
R n (%) |
S n (%) |
R n (%) |
S n (%) |
R n (%) |
S n (%) |
R n (%) |
|
| CRO (30) | 8 (4.8) | 160 (95.2) | 15 (10.6) | 126 (89.4) | 52 (35.4) | 95 (64.6) | 75 (16.4) | 381 (83.6) |
| FOX (30) | 43 (25.6) | 125 (74.4) | 35 (24.8) | 106 (75.2) | 29 (19.7) | 118 (80.3) | 107 (23.5) | 349 (76.5) |
| IPM (10) | 81 (48.2) | 87 (51.8) | 83 (58.9) | 58 (41.1) | 49 (33.3) | 98 (66.7) | 213 (46.7) | 243 (53.3) |
| CAZ (30) | 6 (3.6) | 162 (96.4) | 25 (17.7) | 116 (82.3) | 67 (45.6) | 80 (54.4) | 98 (21.5) | 358 (78.5) |
| ETP (10) | 22 (13.1) | 146 (86.9) | 22 (15.6) | 119 (84.4) | 57 (38.8) | 90 (61.2) | 101 (22.1) | 355 (77.9) |
| OFX (5) | 49 (29.2) | 119 (70.8) | 49 (34.8) | 92 (65.2) | 54 (36.7) | 93 (63.3) | 152 (33.3) | 304 (66.7) |
| GM (10) | 73 (43.5) | 95 (56.5) | 55 (39.0) | 86 (61.0) | 65 (44.2) | 82 (55.8) | 193 (42.3) | 263 (57.7) |
| AK (10) | 59 (35.1) | 109 (64.9) | 67 (47.5) | 74 (52.5) | 53 (36.1) | 94 (63.9) | 179 (39.3) | 277 (60.7) |
| CIP (5) | 31 (18.5) | 137 (81.5) | 19 (13.5) | 122 (86.5) | 28 (19.0) | 119 (81.0) | 78 (17.1) | 378 (82.9) |
| CTX (30) | 3 (1.8) | 165 (98.2) | 5 (3.5) | 136 (96.5) | 30 (20.4) | 117 (79.6) | 38 (8.3) | 418 (91.7) |
| MEM (10) | 75 (44.6) | 93 (55.4) | 80 (56.7) | 61 (43.3) | 58 (39.5) | 89 (60.5) | 213 (46.7) | 243 (53.3) |
| AMP (10) | 50 (29.8) | 118 (70.2) | 43 (30.5) | 98 (69.5) | 28 (19.0) | 119 (81.0) | 121 (26.5) | 335 (73.5) |
| ATM (30) | 11 (6.5) | 157 (93.5) | 5 (3.5) | 136 (96.5) | 61 (41.5) | 86 (58.5) | 77 (16.9) | 379 (83.1) |
S Susceptible, R Resistant, IPM Imipenem, MEM Meropenem, ETP Ertapenem, FOX Cefoxitin, CAZ Ceftazidime, AK Amikacin, GM Gentamicin, CTX Cefotaxime, CRO Ceftriaxone, CIP Ciprofloxacin, OFX Ofloxacin, AMP Ampicillin, ATM Aztreonam